ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART

ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART

The manifold studies on ACE gene impact on left ventricular hypertrophy (LVH) development in hypertrophic cardiomyopathy (HCMP) and arterial hypertension (AH) have provided too contradictory results to clarify the association between ACE gene I/D polymorphism and cardiovascular pathology in these no...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. D. Smirnova, T. V. Fofanova, Z. B. Khasanova, A. G. Ovchinnikov, F. T. Ageev, A. Yu. Postnov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2009-04-01
Series:	Российский кардиологический журнал
Subjects:	hypertrophic cardiomyopathy hypertensive heart id polymorphism left ventricular hypertrophy associations
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1340
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy
by: Hao Cui, et al.
Published: (2025-04-01)

Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists
by: M. D. Smirnova, et al.
Published: (2007-12-01)

Specifics of Left Ventricular Hypertrophy and Characteristic of Phenotypic Variants in Patients with Hypertrophic Cardiomyopathy
by: G. I. Ignatenko, et al.
Published: (2023-08-01)

Clinical manifestation and outcomes of children with hypertrophic cardiomyopathy in Kosovo
by: Ramush A Bejiqi, et al.
Published: (2020-04-01)

The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy
by: Luca Pugliese, et al.
Published: (2025-05-01)

DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY
by: An. A. Aleksandrov, et al.
Published: (2015-09-01)

LEFT VENTRICULAR WALL THICKNESS AND AUTONOMIC REGULATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: O. Allaberganov, et al.
Published: (2011-10-01)

The challenges in diagnosing hypertrophic cardiomyopathy in the presence of arterial hypertension: a clinical case
by: O. O. Khaniukov, et al.
Published: (2024-07-01)

Patterns of left ventricular trabeculation in hypertrophic cardiomyopathy
by: Yu Zhang, et al.
Published: (2025-05-01)

The role of cardiac MRI in risk stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy
by: M. S. Ishchenko, et al.
Published: (2024-05-01)

Left ventricular septal convexity in differentiating hypertrophic cardiomyopathy from hypertensive heart disease – a cardiac magnetic resonance study
by: Mika Tarkiainen, et al.
Published: (2025-08-01)

Apical hypertrophic cardiomyopathy: contemporary view on the prevalence, clinical profile, diagnostic and treatmen (review of literature)
by: A. A. Streltsova, et al.
Published: (2021-10-01)

Septal alcohol ablation in patients with hypertrophic cardiomyopathy and left ventricular outflow tract obstruction
by: Mariia S. Nozdriakova, et al.
Published: (2025-01-01)

Contrast Enhanced Echocardiography-Controlled Alcohol Septal Ablation for Hypertrophic Cardiomyopathy with Left Ventricular Outflow Tract Obstruction
by: I. E. Nikolaeva, et al.
Published: (2019-07-01)

Multidisciplinary approach in the differential diagnosis of left ventricular hypertrophy: a case report
by: M. M. Kudryavtseva, et al.
Published: (2024-03-01)

Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling
by: Malene E. Lindholm, et al.
Published: (2025-07-01)

Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II
by: Yimeng Cui, et al.
Published: (2025-02-01)

Hypertrophic Obstructive Cardiomyopathy Associated with Moderate Aortic Stenosis in Symptomatic 75-Year-Old Female: A Case Report
by: Abdulgani Abonowara
Published: (2023-01-01)

RARE CASES OF HYPERTROPHIC CARDIOMYOPATHY: VARIANTS AND CLINICAL OBSERVATIONS
by: V. Yu. Zimina, et al.
Published: (2015-09-01)

Mavacamten in real‐life practice: Initial experience at a hypertrophic cardiomyopathy centre
by: Zaid Abood, et al.
Published: (2025-02-01)

Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years
by: Daniele Massera, et al.
Published: (2025-01-01)

A case report of ventricular suicide following transcatheter aortic valve replacement for severe aortic stenosis in a patient with hypertrophic cardiomyopathy: the danger of abrupt afterload reduction
by: Kirtivardhan Vashistha, et al.
Published: (2025-06-01)

LEFT VENTRICULAR HYPERTROPHY IN PATIENTS ON CHRONIC HAEMODIALYSIS
by: A. G. Strokov, et al.
Published: (2010-06-01)

The detection of left ventricular hypertrophy and diastolic dysfunction
by: G.R. Norton
Published: (2012-04-01)

Comprehensive Review: Mavacamten and Aficamten in Hypertrophic Cardiomyopathy
by: Helin Savsin, et al.
Published: (2025-07-01)

ANATOMIC AND MORPHOLOGICAL SIGNS OF A DIFFUSE-GENERALIZED HYPERTROPHIC CARDIOMYOPATHY
by: S. L. Dzemeshkevich, et al.
Published: (2015-05-01)

THE SYNDROME OF LEFT VENTRICLE HYPERTROPHY
by: S. L. Dzemeshkevitch, et al.
Published: (2014-09-01)

In search of heart barometer—advantage of left atrial dimension over electrocardiographic indices of left ventricular hypertrophy in arterial hypertension
by: Bogusława Nowak, et al.
Published: (2023-07-01)

PERIOPERATIVE PERIOD FOLLOWING HEART TRANSPLANTATION WITH SEVERE LEFT VENTRICULAR HYPERTROPHY
by: V. N. Poptsov, et al.
Published: (2012-05-01)

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response
by: Anjali T. Owens, et al.
Published: (2024-09-01)

Increased left ventricular mass as a marker of left ventricular hypertrophy in normotensive type 2 DM patients
by: Moustafa Kamal Eldin Ibrahim Khalil Saad, et al.
Published: (2025-03-01)

High‐frequency content within the QRS complex can predict ventricular tachyarrhythmias in hypertrophic cardiomyopathy
by: Takeshi Tsutsumi, et al.
Published: (2025-08-01)

MYOCARDIAL REMODELLING TYPES IN HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY
by: D. V. Bogdanov
Published: (2015-05-01)

Transplantation of cardiac allografts with left ventricular hypertrophy 1.5 cm and more
by: V. N. Poptsov, et al.
Published: (2019-05-01)

Game changer: understanding and managing hypertrophic cardiomyopathy in athletes
by: Maria Kulak, et al.
Published: (2024-09-01)

Microvascular dysfunction causing myocardial ischemia in obstructive hypertrophic cardiomyopathy
by: Nonthikorn Theerasuwipakorn, MD, MSc, et al.
Published: (2025-04-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
by: Sarala Raj Murthi, et al.
Published: (2025-01-01)

Trans-atrial Inflow Cannula Configuration for Durable HeartWare Left Ventricular Assist Device in Hypertrophic Cardiomyopathy: A Case Series and a Word of Caution
by: Darshan H. Brahmbhatt, MB BChir, MD, et al.
Published: (2025-08-01)

High-sensitive cardiac troponin T and NT-proBNP are associated with the left ventricular apical thickness in apical hypertrophic cardiomyopathy
by: Meng Zhang, et al.
Published: (2025-01-01)